SpyGlass Pharma
Filed with the SEC on Β· accession 0001778922-26-000055
SGP filed a 8-K (current report) with the SEC on Nov 12, 2026. SpyGlass Pharma announced its Q3 2026 financial results and disclosed that in October 2026 it completed the first implantations in its first-in-human study of the Bimatoprost-Drug Ring System (BIM-DRS), a non-IOL sustained drug delivery system for glaucoma designed to deliver up to seven years of⦠The stock moved -1.7% by the first close after the filing.
SpyGlass Pharma announced its Q3 2026 financial results and disclosed that in October 2026 it completed the first implantations in its first-in-human study of the Bimatoprost-Drug Ring System (BIM-DRS), a non-IOL sustained drug delivery system for glaucoma designed to deliver up to seven years of bimatoprost.
Close before
$34.97
Nov 11, 2026
First close after
-1.72%
$34.37
5 trading days
β
Since filing
β
β¦ Ask GOAX AI about this filing β what it means for SGP, what changed since its last filings and what to watch next.
Try it free for 7 daysπ Want to stay updated on new SEC filings for SGP?
Click hereSGP filed a 8-K (SEC filing). SpyGlass Pharma announced its Q3 2026 financial results and disclosed that in October 2026 it completed the first implantations in its first-in-human study of the Bimatoprost-Drug Ring System (BIM-DRS), a non-IOL sustained drug delivery system for glaucoma designed to deliver up to seven years of bimatoprost.
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Public companies must tell the SEC about anything that can change their value β results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
SGP closed at $34.97 before the filing and $34.37 on Nov 12, 2026 (-1.72%).
Get alerts when SGP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days